Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP471251.RA_biu-bYGq_qp5_ysCrnfXdc0sRpqOwt59-OYRyxv21U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP471251.RA_biu-bYGq_qp5_ysCrnfXdc0sRpqOwt59-OYRyxv21U130_assertion type Assertion NP471251.RA_biu-bYGq_qp5_ysCrnfXdc0sRpqOwt59-OYRyxv21U130_head.
- NP471251.RA_biu-bYGq_qp5_ysCrnfXdc0sRpqOwt59-OYRyxv21U130_assertion description "[HIF-1 is also activated in cancer cells by tumor suppressor (e.g., VHL) loss of function and oncogene gain of function (leading to PI3K/AKT/mTOR activity) and mediates metabolic alterations that drive cancer progression and resistance to therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP471251.RA_biu-bYGq_qp5_ysCrnfXdc0sRpqOwt59-OYRyxv21U130_provenance.
- NP471251.RA_biu-bYGq_qp5_ysCrnfXdc0sRpqOwt59-OYRyxv21U130_assertion evidence source_evidence_literature NP471251.RA_biu-bYGq_qp5_ysCrnfXdc0sRpqOwt59-OYRyxv21U130_provenance.
- NP471251.RA_biu-bYGq_qp5_ysCrnfXdc0sRpqOwt59-OYRyxv21U130_assertion SIO_000772 23999440 NP471251.RA_biu-bYGq_qp5_ysCrnfXdc0sRpqOwt59-OYRyxv21U130_provenance.
- NP471251.RA_biu-bYGq_qp5_ysCrnfXdc0sRpqOwt59-OYRyxv21U130_assertion wasDerivedFrom befree-20140225 NP471251.RA_biu-bYGq_qp5_ysCrnfXdc0sRpqOwt59-OYRyxv21U130_provenance.
- NP471251.RA_biu-bYGq_qp5_ysCrnfXdc0sRpqOwt59-OYRyxv21U130_assertion wasGeneratedBy ECO_0000203 NP471251.RA_biu-bYGq_qp5_ysCrnfXdc0sRpqOwt59-OYRyxv21U130_provenance.